Contents

Search


trimethylamine

Pathology: - proatherogenic molecule generated from dietary components by gut bacteria [1,2] - gut bacteria convert dietary carnitine & phosphatidylcholine (lecithin) to trimethylamine-N-oxide that is absorbed - trimethylamine is converted to trimethylamine-N-oxide by the liver & appears in plasma

Specific

trimethylamine-N-oxide (TMAO)

General

amine

Database Correlations

PUBCHEM cid=1146

References

  1. Tang WHW et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013 Apr 25; 368:1575 PMID: 23614584 http://www.nejm.org/doi/full/10.1056/NEJMoa1109400 - Loscalzo J. Gut microbiota, the genome, and diet in atherogenesis. N Engl J Med 2013 Apr 25; 368:1647. PMID: 23614591 http://www.nejm.org/doi/full/10.1056/NEJMe1302154
  2. Wang Z, Roberts AB, Buffa JA et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 2015 Dec 17; 163:1585 PMID: 26687352